Advertisement

Topics

Comparing GLP-1 Agonists

08:39 EST 6 Mar 2018 | AHC Media

There are more similarities than differences among the seven currently available glucagon-like peptide-1 (GLP-1) receptor agonists. The most recently FDA-approved GLP-1 receptor agonist, once-weekly semaglutide (Ozempic), was compared in a head-to-head trial to once-weekly exenatide-ER (Bydureon).

Original Article: Comparing GLP-1 Agonists

NEXT ARTICLE

More From BioPortfolio on "Comparing GLP-1 Agonists"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...